XSLI.DE
Xtrackers SLI UCITS ETF 1D
Europe
EQUITY
Passive
MANAGEMENT STYLE
€ 419.7 M
ASSETS UNDER MGMT
25 bp
EXPENSES
Fund Basics
| Inception date | Jan 25, 2008 |
| Regulation | UCITS |
| Fund Website | link... |
| Distributions | |
| Currency | EUR |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| UBS GROUP AG | 10.7 % |
| ROCHE PS PAR | 8.7 % |
| NOVARTIS AG-REG | 8.4 % |
| NOVARTIS AG | 8.4 % |
| NESTLE SA-REG | 8.4 % |
| ABB LTD. | 5.3 % |
| CIE FINANCIERE RICHEMON-BR A | 4.8 % |
| ZURICH FINANCIAL SERVICES AG | 4.6 % |
| HOLCIM LTD-REG | 4.4 % |
| SWISS RE AG | 3.9 % |
Constituent Breakdown
| Number of holdings | 32 |
| Herfindahl-Hirschman Index | 593 |
| Wgt avg mkt cap (mns) | $119,196 |
| Large cap (>$10bn) | 93.5% |
| Mid cap ($2-10bn) | 0.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 98.9% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
SWITZERLAND | 96.2 % |
 |
UNITED STATES | 2.3 % |
Historical Performance
Standardized Performance (as of 06/03/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -- | -- | -- | -- | -- | -- | -- | -- |
| Dividend Yield | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Returns | -- | -- | -- | -- | -- | -- | -- | -- | Ann. Volatility | -- | -- | -- | -- | -- | -- | -- | -- |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.00 | 0% |
| MSCI EAFE | 0.00 | 0% |
| MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
| Avg. volume (000) | 0 |
| ADV traded (mns) | $0 |
| Turnover | 0.0% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $0.00 |
| Relative strength (RSI) | 0 |
| MACD/Signal | 0.00/0.00 |
| Bollinger Bands (Upper/Lower) | $0.00/$0.00 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. XSLI.DE |
Expenses vs. XSLI.DE |
ALTAR Score™ vs. XSLI.DE |
|---|---|---|---|---|
| XSMC.SW | Xtrackers Switzerland UCITS ETF 1C | 70.4% | +5 bp | -0.2% |
| XSMI.DE | Xtrackers Switzerland UCITS ETF 1D | 69.9% | +5 bp | -0.2% |
| C030.DE | Amundi DJ Switzerland Titans 30 UCITS ETF Dist | 69.0% | 0 bp | -0.9% |
| XSDR.DE | Xtrackers MSCI Europe Health Care Screened UCITS ETF 1C | 24.5% | -8 bp | +1.1% |
| XZEC.DE | Xtrackers Stoxx European Market Leaders UCITS ETF 1C | 22.3% | 0 bp | 0.0% |
| XZEP.DE | Xtrackers MSCI Europe ESG UCITS ETF 1D | 20.9% | -7 bp | -0.1% |
| XZEU.DE | Xtrackers MSCI Europe ESG UCITS ETF 1C | 20.9% | -5 bp | -0.2% |
| XUEK.L | Xtrackers S&P Europe ex UK UCITS ETF 1D | 17.2% | -16 bp | +0.4% |
| ESIH.L | iShares MSCI Europe Health Care Sector UCITS ETF | 16.5% | -7 bp | +1.1% |
| EXV4.DE | iShares STOXX Europe 600 Health Care UCITS ETF (DE) | 16.5% | +21 bp | +0.7% |
Risk and Returns: XSLI.DE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (EUR)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/3/2026
Peer Group Comparison
Sample data. Subscribe for access.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.5%
ALTAR SCORE™
40th
PERCENTILE
NEUTRAL
ETFRC RATING
There are 237 funds in the Europe Equity category with an average
ALTAR Score™ of 6.8% and a standard deviation
of 1.3%. XSLI.DE's ALTAR Score™ is approximately -0.3 standard
deviations above the category average. This places XSLI.DE in the 40th percentile
among funds in the category.
Sell-Side Consensus
€253.7
PRICE TARGET
+4.2%
UPSIDE